Sea You at Fetch Long Beach
|Articles|July 1, 2006

Flunixin Meglumine Injection

Madison, N.J. - Fort Dodge Animal Health announces the U.S. Food and Drug Administration (FDA) approved the use of Flunixamine? (flunixin meglumine injection) in lactating dairy cows.

MADISON, N.J. — Fort Dodge Animal Health announces the U.S. Food and Drug Administration (FDA) approved the use of Flunixamine® (flunixin meglumine injection) in lactating dairy cows. Flunixamine provides producers with a safe and effective support therapy to control fever associated with bovine respiratory disease (BRD) and fever and inflammation associated with endotoxemia, which are potentially deadly health issues for dairy cattle, the company says.

Flunixamine provides relief by reducing pyrexia associated with BRD and endo toxemia and helps control inflammation caused by endotoxemia. Flunixamine has a 36-hour milk withdrawal and four-day meat withdrawal in lactating dairy cows and heifers.

Flunixamine is available to dairy producers through veterinarians.

For fastest response, call

(800) 533-8536

www.wyeth.com


Related to this article

Combating corporate crawl
Big business has tilted the balance in the American veterinary industry, as resources and economies of scale turn corporate chains into powerful foes for hospitals set on remaining independent.